Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

1.

Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.

Kim MJ, Shin HC, Shin KC, Ro JY.

Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.

PMID:
23040737
[PubMed - indexed for MEDLINE]
2.

Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.

Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.

Arch Pathol Lab Med. 2012 Feb;136(2):155-62. doi: 10.5858/arpa.2011-0232-OA.

PMID:
22288962
[PubMed - indexed for MEDLINE]
3.

Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.

Tsuta K, Tanabe Y, Yoshida A, Takahashi F, Maeshima AM, Asamura H, Tsuda H.

J Thorac Oncol. 2011 Jul;6(7):1190-9. doi: 10.1097/JTO.0b013e318219ac78.

PMID:
21623236
[PubMed - indexed for MEDLINE]
4.

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

Mukhopadhyay S, Katzenstein AL.

Am J Surg Pathol. 2011 Jan;35(1):15-25. doi: 10.1097/PAS.0b013e3182036d05.

PMID:
21164283
[PubMed - indexed for MEDLINE]
6.

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, Popat S.

J Thorac Oncol. 2010 Apr;5(4):436-41. doi: 10.1097/JTO.0b013e3181c6ed9b.

PMID:
20068475
[PubMed - indexed for MEDLINE]
7.

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.

Brown AF, Sirohi D, Fukuoka J, Cagle PT, Policarpio-Nicolas M, Tacha D, Jagirdar J.

Arch Pathol Lab Med. 2013 Sep;137(9):1274-81. doi: 10.5858/arpa.2012-0635-OA. Epub 2013 Jan 4.

PMID:
23289761
[PubMed - indexed for MEDLINE]
8.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

PMID:
21623384
[PubMed - indexed for MEDLINE]
Free Article
9.

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN.

Am J Surg Pathol. 2010 Dec;34(12):1805-11. doi: 10.1097/PAS.0b013e3181f7dae3.

PMID:
21107086
[PubMed - indexed for MEDLINE]
10.

Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.

Warth A, Muley T, Herpel E, Meister M, Herth FJ, Schirmacher P, Weichert W, Hoffmann H, Schnabel PA.

Histopathology. 2012 Dec;61(6):1017-25. doi: 10.1111/j.1365-2559.2012.04308.x. Epub 2012 Aug 8.

PMID:
22882703
[PubMed - indexed for MEDLINE]
11.

Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.

Noh S, Shim H.

Lung Cancer. 2012 Apr;76(1):51-5. doi: 10.1016/j.lungcan.2011.09.008. Epub 2011 Oct 5.

PMID:
21978426
[PubMed - indexed for MEDLINE]
12.

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.

Sethi S, Geng L, Shidham VB, Archuletta P, Bandyophadhyay S, Feng J, Madan S, Shi D, Tranchida P, Giorgadze T.

Cytojournal. 2012;9:10. doi: 10.4103/1742-6413.94570. Epub 2012 Mar 31.

PMID:
22582081
[PubMed]
Free PMC Article
13.

Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.

Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM.

J Thorac Oncol. 2010 Apr;5(4):442-7. doi: 10.1097/JTO.0b013e3181d40fac.

PMID:
20195168
[PubMed - indexed for MEDLINE]
14.

Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.

Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):313-7. doi: 10.1097/PAI.0b013e318205b059.

PMID:
21464700
[PubMed - indexed for MEDLINE]
15.

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.

Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z.

Diagn Cytopathol. 2009 Mar;37(3):178-83. doi: 10.1002/dc.20975.

PMID:
19170169
[PubMed - indexed for MEDLINE]
16.

Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.

Brunnström H, Johansson L, Jirström K, Jönsson M, Jönsson P, Planck M.

Am J Clin Pathol. 2013 Jul;140(1):37-46. doi: 10.1309/AJCP50RDXSCSBTBO.

PMID:
23765532
[PubMed - indexed for MEDLINE]
Free Article
17.

Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.

Turner BM, Cagle PT, Sainz IM, Fukuoka J, Shen SS, Jagirdar J.

Arch Pathol Lab Med. 2012 Feb;136(2):163-71. doi: 10.5858/arpa.2011-0320-OA.

PMID:
22288963
[PubMed - indexed for MEDLINE]
18.

Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.

Johnson H, Cohen C, Fatima N, Duncan D, Siddiqui MT.

Acta Cytol. 2012;56(6):596-602. doi: 10.1159/000339793. Epub 2012 Nov 24.

PMID:
23207437
[PubMed - indexed for MEDLINE]
19.

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.

Bishop JA, Sharma R, Illei PB.

Hum Pathol. 2010 Jan;41(1):20-5. doi: 10.1016/j.humpath.2009.06.014. Epub 2009 Sep 8.

PMID:
19740516
[PubMed - indexed for MEDLINE]
20.

Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas.

Sinna EA, Ezzat N, Sherif GM.

J Egypt Natl Canc Inst. 2013 Dec;25(4):209-18. doi: 10.1016/j.jnci.2013.05.005. Epub 2013 Aug 19.

PMID:
24207093
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk